Celularity CEO & Chairman Resigns, New Leadership Appointed
Ticker: CELUW · Form: 8-K · Filed: Sep 13, 2024 · CIK: 1752828
Sentiment: neutral
Topics: leadership-change, management-transition
Related Tickers: CELU
TL;DR
Celularity CEO & Chairman Hariri out, Deitcher in as of July 24th.
AI Summary
Celularity Inc. announced on July 24, 2024, a change in its board of directors. Specifically, Dr. Robert J. Hariri has resigned from his position as Chief Executive Officer and Chairman of the Board. Concurrently, Dr. Steven J. Deitcher has been appointed as the new Chief Executive Officer and Chairman of the Board.
Why It Matters
This leadership change at Celularity Inc. could signal a shift in the company's strategic direction and operational focus, potentially impacting its stock performance and future development plans.
Risk Assessment
Risk Level: medium — Leadership changes, especially at the CEO and Chairman level, introduce uncertainty regarding future strategy and execution, which can be a medium-term risk.
Key Players & Entities
- Celularity Inc. (company) — Registrant
- Dr. Robert J. Hariri (person) — Resigning CEO and Chairman
- Dr. Steven J. Deitcher (person) — Appointed CEO and Chairman
- July 24, 2024 (date) — Date of earliest event reported
FAQ
Who has resigned from Celularity Inc. and what were their roles?
Dr. Robert J. Hariri has resigned from his positions as Chief Executive Officer and Chairman of the Board of Celularity Inc.
Who has been appointed as the new CEO and Chairman of Celularity Inc.?
Dr. Steven J. Deitcher has been appointed as the new Chief Executive Officer and Chairman of the Board of Celularity Inc.
What is the exact date of the reported event?
The date of the earliest event reported is July 24, 2024.
What is Celularity Inc.'s state of incorporation?
Celularity Inc. is incorporated in Delaware.
What was Celularity Inc.'s former company name?
Celularity Inc.'s former company name was GX Acquisition Corp.
Filing Stats: 460 words · 2 min read · ~2 pages · Grade level 9.8 · Accepted 2024-09-13 17:15:11
Key Financial Figures
- $0.0001 — hich registered Class A Common Stock, $0.0001 par value per share CELU The Nasdaq
- $11.50 — A Common Stock at an exercise price of $11.50 per share CELUW The Nasdaq Stock Ma
Filing Documents
- form8-k.htm (8-K) — 40KB
- 0001493152-24-036234.txt ( ) — 260KB
- celu-20240724.xsd (EX-101.SCH) — 4KB
- celu-20240724_def.xml (EX-101.DEF) — 29KB
- celu-20240724_lab.xml (EX-101.LAB) — 36KB
- celu-20240724_pre.xml (EX-101.PRE) — 27KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CELULARITY INC. Date: September 13, 2024 By: /s/ Robert J. Hariri Robert J. Hariri, M.D., Ph.D. Chairman and CEO